 |
|
Home | Enzo Biochem Stock Rating Lowered by Zacks (ENZ) |
 |
Enzo Biochem Stock Rating Lowered by Zacks (ENZ)
|
 |
- May 25, 2015
-
Enzo Biochem (NYSE:ENZ) was downgraded by Zacks from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Monday. Zacks’ analyst wrote, “Enzo Biochem, Inc. develops, manufactures and markets health care products based on molecular biology and genetic engineering techniques, and also provides diagnostic services to the medical […]This article (Enzo Biochem Stock Rating Lowered by Zacks (ENZ)) was originally developed by and is property of American Banking News.
Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.
- Read more at:http://www.americanbankingnews.com/2015/05/24/enzo-biochem-stock-rating-lowered-by-zacks-enz/
|
 |
|
 |
|
 |
